6533b821fe1ef96bd127b63e
RESEARCH PRODUCT
false
subject
0301 basic medicineDiseaseBiologyCatalysisInorganic Chemistry03 medical and health sciencesTuberous sclerosisEpilepsy0302 clinical medicinemedicinePhysical and Theoretical ChemistryMolecular BiologySpectroscopyOrganic ChemistryGlutamate receptorGeneral Medicinemedicine.diseasePhenotypeComputer Science Applications030104 developmental biologymedicine.anatomical_structureAutismTSC1TSC2Neuroscience030217 neurology & neurosurgerydescription
Mutations in TSC1 or TSC2 genes are linked to alterations in neuronal function which ultimately lead to the development of a complex neurological phenotype. Here we review current research on the effects that reduction in TSC1 or TSC2 can produce on the developing neural network. A crucial feature of the disease pathophysiology appears to be an early deviation from typical neurodevelopment, in the form of structural abnormalities. Epileptic seizures are one of the primary early manifestation of the disease in the CNS, followed by intellectual deficits and autism spectrum disorders (ASD). Research using mouse models suggests that morphological brain alterations might arise from the interaction of different cellular types, and hyperexcitability in the early postnatal period might be transient. Moreover, the increased excitation-to-inhibition ratio might represent a transient compensatory adjustment to stabilize the developing network rather than a primary factor for the development of ASD symptoms. The inhomogeneous results suggest region-specificity as well as an evolving picture of functional alterations along development. Furthermore, ASD symptoms and epilepsy might originate from different but potentially overlapping mechanisms, which can explain recent observations obtained in patients. Potential treatment is determined not only by the type of medicament, but also by the time point of treatment.
year | journal | country | edition | language |
---|---|---|---|---|
2021-07-06 | International Journal of Molecular Sciences |